Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
21.56
+0.30 (1.41%)
May 26, 2026, 4:00 PM EDT - Market closed
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Pediatrix Medical Group stock has a consensus rating of "Buy" and an average price target of $23.17. The average 1-year stock price forecast is 7.47% higher than the current stock price, while the lowest is $19 (-11.87%) and the highest is $27 (+25.23%).
Price Target: $23.17 (+7.47%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pediatrix Medical Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $22 → $25 | Hold | Maintains | $22 → $25 | +15.96% | May 12, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Maintains $21 → $24 | Hold | Maintains | $21 → $24 | +11.32% | May 8, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $23 | Hold | Maintains | $23 | +6.68% | May 6, 2026 |
| William Blair | William Blair | Buy Reiterates $22 | Buy | Reiterates | $22 | +2.04% | May 5, 2026 |
| Jefferies | Jefferies | Buy Maintains $24 → $27 | Buy | Maintains | $24 → $27 | +25.23% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
2.00B
from 1.91B
Increased by 4.45%
Revenue Next Year
2.05B
from 2.00B
Increased by 2.45%
EPS This Year
2.35
from 1.94
Increased by 21.22%
EPS Next Year
2.43
from 2.35
Increased by 3.49%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 2.0B | 2.1B | ||
| Avg | 2.0B | 2.0B | ||
| Low | 1.9B | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 6.7% | 6.1% | ||
| Avg | 4.4% | 2.5% | ||
| Low | -0.9% | -4.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 2.49 | 2.72 | ||
| Avg | 2.35 | 2.43 | ||
| Low | 2.16 | 2.08 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 28.3% | 15.6% | ||
| Avg | 21.2% | 3.5% | ||
| Low | 11.1% | -11.7% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.